20
Participants
Start Date
October 2, 2023
Primary Completion Date
November 22, 2023
Study Completion Date
March 15, 2024
Active Comparator: Study Group A: Blis Q24 Serum at higher dose
Active Comparator: Study Group A: Blis Q24 Serum at 1e7 cfu/ dose (Active)
Active Comparator: Study Group B: Blis Q24 Serum at lower dose
Active Comparator: Study Group B: Blis Q24 Serum at 1e6 cfu/ dose (Active)
Blis Technologies Ltd, Dunedin
Lead Sponsor
BLIS Technologies Limited
INDUSTRY